190 related articles for article (PubMed ID: 26777440)
1. Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation.
Kelkar MG; Senthilkumar K; Jadhav S; Gupta S; Ahn BC; De A
Sci Rep; 2016 Jan; 6():19341. PubMed ID: 26777440
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor protein p53 exerts negative transcriptional regulation on human sodium iodide symporter gene expression in breast cancer.
Kelkar MG; Thakur B; Derle A; Chatterjee S; Ray P; De A
Breast Cancer Res Treat; 2017 Aug; 164(3):603-615. PubMed ID: 28528452
[TBL] [Abstract][Full Text] [Related]
3. The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS).
Fortunati N; Catalano MG; Marano F; Mugoni V; Pugliese M; Bosco O; Mainini F; Boccuzzi G
Breast Cancer Res Treat; 2010 Dec; 124(3):667-75. PubMed ID: 20213084
[TBL] [Abstract][Full Text] [Related]
4. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
Dwyer RM; Bergert ER; O'connor MK; Gendler SJ; Morris JC
Clin Cancer Res; 2005 Feb; 11(4):1483-9. PubMed ID: 15746050
[TBL] [Abstract][Full Text] [Related]
5. Telomerase-driven expression of the sodium iodide symporter (NIS) for in vivo radioiodide treatment of cancer: a new broad-spectrum NIS-mediated antitumor approach.
Riesco-Eizaguirre G; De la Vieja A; Rodríguez I; Miranda S; Martín-Duque P; Vassaux G; Santisteban P
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1435-43. PubMed ID: 21697253
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors.
Dwyer RM; Bergert ER; O'Connor MK; Gendler SJ; Morris JC
Hum Gene Ther; 2006 Jun; 17(6):661-8. PubMed ID: 16776574
[TBL] [Abstract][Full Text] [Related]
7. Effects of histone acetylation on sodium iodide symporter promoter and expression of thyroid-specific transcription factors.
Puppin C; D'Aurizio F; D'Elia AV; Cesaratto L; Tell G; Russo D; Filetti S; Ferretti E; Tosi E; Mattei T; Pianta A; Pellizzari L; Damante G
Endocrinology; 2005 Sep; 146(9):3967-74. PubMed ID: 15919754
[TBL] [Abstract][Full Text] [Related]
8. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
[TBL] [Abstract][Full Text] [Related]
9. Use of rhenium-188 for in vivo imaging and treatment of human cervical cancer cells transfected with lentivirus expressing sodium iodide symporter.
Zhang M; Shi S; Guo R; Miao Y; Li B
Oncol Rep; 2016 Oct; 36(4):2289-97. PubMed ID: 27573304
[TBL] [Abstract][Full Text] [Related]
10. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
[TBL] [Abstract][Full Text] [Related]
11. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice.
Dwyer RM; Bergert ER; O'Connor MK; Gendler SJ; Morris JC
Gene Ther; 2006 Jan; 13(1):60-6. PubMed ID: 16121204
[TBL] [Abstract][Full Text] [Related]
12. Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer.
Yao C; Pan Y; Li Y; Xu X; Lin Y; Wang W; Wang S
Oncol Rep; 2015 Jul; 34(1):59-66. PubMed ID: 25955347
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin.
Furuya F; Shimura H; Suzuki H; Taki K; Ohta K; Haraguchi K; Onaya T; Endo T; Kobayashi T
Endocrinology; 2004 Jun; 145(6):2865-75. PubMed ID: 14976143
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells.
Jung KH; Paik JY; Ko BH; Lee KH
J Nucl Med; 2008 Dec; 49(12):1966-72. PubMed ID: 18997042
[TBL] [Abstract][Full Text] [Related]
15. Signaling through 3',5'-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer.
Knostman KA; Cho JY; Ryu KY; Lin X; McCubrey JA; Hla T; Liu CH; Di Carlo E; Keri R; Zhang M; Hwang DY; Kisseberth WC; Capen CC; Jhiang SM
J Clin Endocrinol Metab; 2004 Oct; 89(10):5196-203. PubMed ID: 15472226
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.
Müller AM; Schmohl KA; Knoop K; Schug C; Urnauer S; Hagenhoff A; Clevert DA; Ingrisch M; Niess H; Carlsen J; Zach C; Wagner E; Bartenstein P; Nelson PJ; Spitzweg C
Oncotarget; 2016 Aug; 7(34):54795-54810. PubMed ID: 27458162
[TBL] [Abstract][Full Text] [Related]
17. In vivo radioiodide imaging and treatment of pancreatic cancer xenografts after MUC1 promoter-driven expression of the human sodium-iodide symporter.
Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Yu FY; Zhou QB; Wang J; Chen JS
Pancreatology; 2007; 7(5-6):505-13. PubMed ID: 17912014
[TBL] [Abstract][Full Text] [Related]
18. Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer.
Trujillo MA; Oneal MJ; Davydova J; Bergert E; Yamamoto M; Morris JC
Breast Cancer Res; 2009; 11(4):R53. PubMed ID: 19635153
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.
Willhauck MJ; O Kane DJ; Wunderlich N; Göke B; Spitzweg C
Breast Cancer Res Treat; 2011 Jan; 125(2):377-86. PubMed ID: 20300827
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells.
Kogai T; Kanamoto Y; Li AI; Che LH; Ohashi E; Taki K; Chandraratna RA; Saito T; Brent GA
Endocrinology; 2005 Jul; 146(7):3059-69. PubMed ID: 15817668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]